Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pauline Wils

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Alimentary Pharmacology & Therapeutics|January 11, 2021
Editorial: keep calm and carry on-managing non-TNF antagonist biologics in pregnancy-authors' replyPauline Wils, Benjamin Pariente
La Revue Du Praticien|March 15, 2019
[Inflammatory bowel diseases in adults and children]Pauline Wils, Benjamin Pariente
La Revue Du Praticien|March 15, 2019
[Crohn's disease or ulcerative colitis?]Pauline Wils, Benjamin Pariente
Immunotherapy|February 15, 2023
Etrasimod for the treatment of ulcerative colitisPauline Wils, Laurent Peyrin-Biroulet
Gastroenterology|March 30, 2016
ReplyBenjamin Pariente, Pauline Wils, David Laharie
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 12, 2025
Author's reply: "Navigating anti-TNF therapy risks: Real-world insights on pregnancy, breastfeeding, and vaccines in IBD patients"Pauline Wils, Marion Simon, Anthony Buisson
Expert Opinion on Investigational Drugs|May 30, 2023
Promising phase II biologics for future Crohn's disease therapyPauline Wils, Silvio Danese, Laurent Peyrin-Biroulet
Journal of Clinical Medicine|July 27, 2022
Abdominal Pain in Inflammatory Bowel Diseases: A Clinical ChallengePauline Wils, Bénédicte Caron, Ferdinando D'Amico, et al.
Therapeutic Advances in Gastroenterology|March 28, 2025
Switching from intravenous to subcutaneous infliximab is safe and feasible in patients with perianal Crohn's diseasePauline Wils, Mathurin Fumery, Maria Nachury, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2023
Washout Periods in Inflammatory Bowel Disease Trials: A Systematic Literature Review and Proposed SolutionsPauline Wils, Vipul Jairath, Bruce E Sands, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Alimentary Pharmacology & Therapeutics|January 11, 2021
Editorial: keep calm and carry on-managing non-TNF antagonist biologics in pregnancy-authors' replyPauline Wils, Benjamin Pariente
La Revue Du Praticien|March 15, 2019
[Inflammatory bowel diseases in adults and children]Pauline Wils, Benjamin Pariente
La Revue Du Praticien|March 15, 2019
[Crohn's disease or ulcerative colitis?]Pauline Wils, Benjamin Pariente
Immunotherapy|February 15, 2023
Etrasimod for the treatment of ulcerative colitisPauline Wils, Laurent Peyrin-Biroulet
Gastroenterology|March 30, 2016
ReplyBenjamin Pariente, Pauline Wils, David Laharie
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 12, 2025
Author's reply: "Navigating anti-TNF therapy risks: Real-world insights on pregnancy, breastfeeding, and vaccines in IBD patients"Pauline Wils, Marion Simon, Anthony Buisson
Expert Opinion on Investigational Drugs|May 30, 2023
Promising phase II biologics for future Crohn's disease therapyPauline Wils, Silvio Danese, Laurent Peyrin-Biroulet
Journal of Clinical Medicine|July 27, 2022
Abdominal Pain in Inflammatory Bowel Diseases: A Clinical ChallengePauline Wils, Bénédicte Caron, Ferdinando D'Amico, et al.
Therapeutic Advances in Gastroenterology|March 28, 2025
Switching from intravenous to subcutaneous infliximab is safe and feasible in patients with perianal Crohn's diseasePauline Wils, Mathurin Fumery, Maria Nachury, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2023
Washout Periods in Inflammatory Bowel Disease Trials: A Systematic Literature Review and Proposed SolutionsPauline Wils, Vipul Jairath, Bruce E Sands, et al.
Pageof 6